| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Farmarin Indústria e Comércio Ltda [Automatic translation follows] Valuing Lives! Since 1988, Farmarin has been a pioneer in the production of Polyelectrolytic Concentrates for Hemodialysis (PCHD) in the national market in the nephrology sector. Initially established to supply some hemodialysis clinics in the city of São Paulo, it has experienced exponential growth over the years, meeting the growing demand for its products. In 2000, it moved its facilities to the city of Guarulhos, and began producing on an industrial scale to serve the national and international markets. It is currently investing in new products to serve the hospital sector in the country. In 2012, it … | 0 | 0 | 0 | 386 |
 | Takeda in Belgium Better Health, Brighter Future Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history, originating in Japan. As a global leader with presence in over 80 countries and regions, our therapeutics focus on Gastro-enterology, Oncology, Rare Diseases, Neuroscience, Plasma-Derived Therapies and Vaccines. In Belgium, Takeda is one of the 10 largest pharmaceutical companies, with its local head office located in Zaventem, close to Brussels Airport. Day after day, our … Type: | 5 | 2 | 3 | 257 |
 | BePharBel Manufacturing SA HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder … Type: | 0 | 0 | 0 | 95 |
 | Biomeca® Creator of solutions *A deep expertise in Biomechanics and Surface Analysis in Life Science* Living systems has to be considered as physical systems so that unravelling the physical mechanisms involved in complex biological processes and diseases is one of the main challenges of biology. In BioMeca we believe that the starting point is to give a quantitative physical description of biological samples to have a better understanding of such processes. BioMeca® is a company based in Lyon expert in biomechanics and mechanobiology and specialized in high-resolution structural and mechanical characterization of biological samples at different scales, from large structures, such … Type: | 8 | 3 | 5 | 7 |
 | ENTEROSYS - Gut Is The Link Preclinical studies in gut and gut brain for therapies of tomorrow 🔬 About ENTEROSYS At ENTEROSYS, we are science enthusiasts 🧪 driven by a conviction deeply rooted in medical history: for over two millennia, it has been acknowledged that the key to understanding many diseases lies in our digestive system and its interactions with other organs. Based on this ancient wisdom, we have embraced a modern and holistic approach focused on digestive physiology and the communication between the gut and peripheral organs. Specializing in the preclinical evaluation of compounds with therapeutic potential 💊, we utilize cutting-edge techniques to analyze physiological … Type: | 1 | 1 | 0 | 10 |
 | IPRASENSE Cell Culture Monitoring Instruments IPRASENSE revolutionizes cell analysis with innovative technologies for automated cell counting and real-time visualization, ideal for research and quality control. Cell culture monitoring, Lensless Lensfree Imaging, Video microscopy, Time lapse Imaging, Automatic cell count and viability analysis, High throughput cell, Inside your incubator, cell count, cell counting, cell viability, cell viability analysis , cell monitoring, and angiogenesis Type: | 1 | 0 | 0 | 6 |
 |  QUALIPLANTE Your best partner in plant health testing Qualiplante is a French start-up specialized in the development, the production and the commercialisation of innovative molecular diagnostic tools for the detection of plant diseases. Find the best tool for your plant health testing! Qualiplante offers to plant certification laboratories and all actors of agro-food industry, rapid and easy-to-use all-inclusive molecular kits that permit to detect, in a reliable and sensitive way, pathogens on crops. Validated by worldwide scientific experts, they include all the tools to perform a molecular analysis (ready-to-use master mix, positive and negative controls, analysis protocol). Thanks to the new … Type: | 0 | 0 | 0 | 1 |
 | SkinDermic Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. Type: | 0 | 0 | 0 | 5 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | Anova-Plus [Automatic translation follows] Our mission: to make our genetic and agronomic experiences available to the agro-industry by creating tools Anova-Plus is an innovative company labeled GENOPOLE, created in 2012. We improve plant health for better animal and human well-being and develop early diagnostic tools to better understand crop enemies and thus better combat them. Innovation in favor of sustainable, responsible and environmentally friendly agriculture is a fundamental point in our company's approaches and projects. Our Flashdiag® and MULTIgene® kits allow precise characterization of pathogens and weeds in order to optimize the technical itineraries of agricultural production. Biotechnology, Plant pathology, Plant … Type: | 2 | 1 | 1 | 4 |
 | SynHelix (now Quantoom Biosciences, a Univercells Company) Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology Type: | 2 | 2 | 1 | 7 |
 | OxiProteomics Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a technology-based start-up committed to promoting the healthy living and healthy aging of human population. We deliver proven science services to dermo-cosmetic and food industries to support marketing claims. We also offer environmental quality bio-monitoring solutions to promote sustainable development. OxiProteomics patented technologies are based on the direct and specific detection of functional high quality proteins vs. oxidatively damaged (carbonylated) in biological samples, with a remarkably specificity and sensitivity. We can detect and quantify for the first time, the quality of thousands proteins … Type: | 3 | 1 | 2 | 14 |
 | G.CLIPS biotech ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization … Type: | 12 | 2 | 6 | 6 |
 | MEGA BIOPHARMA [Automatic translation follows] Healing the living with care French player in marine biotechnology, pioneer in the development of Bionacre®, a natural biomaterial extracted from mother-of-pearl. Type: | 1 | 1 | 0 | 19 |
 | Syntivia Preclinical and R&D expertise for skin health care Syntivia is a research laboratory that creates and develops active compounds for dermatology and cosmetics in partnership with its customers. Our experts use the latest chemistry and extraction tools and techniques to create effective active compounds. We develop our own skin models and use the latest cellular/molecular biology and imaging techniques to build solid scientific dossiers demonstrating product efficacy. Syntivia est Laboratoire de rechercher qui créé et développe en partenariat avec ses clients des composés actifs pour la dermatologie et la cosmétique. Nos experts mettent en œuvre les derniers outils et techniques … Type: | 0 | 0 | 0 | 10 |
 | INFYNITY BIOMARKERS SAS Maximizing Immunoassays Performances InfYnity Biomarkers was founded in 2009 in Lyon (France). We are an R&D In-Vitro Diagnostics Company fully dedicated to infectious diseases and immunity. Company Mission: Maximizing Immunoassay Performance i.e. we have the ambition to set new criteria for immunoassays: study the diversity of immune response to provide high-value information instead of the binary response. Our Offer: - High quality, custom-made biomaterial (antigens and antibodies) - RUO Multiplex Immunoassays - Tailored immunobiology services ranging from biomaterial design to biomarker discovery and immunoassay development. Our originality and strength relies on a unique combination of proven skills: Multiplex technology AND … Type: | 0 | 0 | 0 | 6 |
 | IRB Barcelona International biomedical #research center devoted to curing #cancer and other diseases linked to #aging. CERCA-BIST. We are a biomedical research centre that works to achieve a society free of diseases. Our research purpose is to address fundamental biological questions in order to decipher why diseases develop and find new ways to diagnose, prevent and treat them. Our Institute holds more than 500 scientists and support staff from 41 nationalities. It is organised around three major research challenges: Cancer Science, Aging and Metabolism, and Mechanisms of Disease. The Institute was created by the Catalan government in 2005 and is located at … Type: | 26 | 9 | 19 | 478 |
 | CNS Summit Collaborating for Novel Solutions! Now in our 15th year, CNS Summit was created by life science leaders to advance clinical development, with a focus on collaboration, innovation, and technology. The CNS Summit is a community of innovators and industry leaders who are not afraid to challenge the status quo. CNS Summit convenes 1000+ decision-makers from organizations involved in clinical development, healthcare innovation, regulatory authorities, investigator sites, and service companies. At CNS Summit, you will experience emerging technologies with practical applications, curated networking and idea sharing, and create collaborative opportunities to propel the future of drug development. You will return to … Type: | 39 | 4 | 35 | 722 |
 | Riksförbundet Sällsynta diagnoser - Rare Diseases Sweden Sällsynt men inte ovanlig Rare diseases Sweden is a national association representing over 70 rare diseases patient organizations with over 16 000 members. We are the voice of people affected by rare diseases in Sweden. Rare Diseases Sweden was founded in 1998 and has steadily grown in size and success, making rare diseases increasingly known. We work diligently to spread awareness, influence political decision making and improve healthcare for people living with rare diseases. A rare disease is any disease that affects a small percentage of the population, is often of genetic origin, and is present throughout a person’s life … Type: | 2 | 0 | 2 | 6 |
 | Selexis SA Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, … Type: | 4 | 1 | 0 | 31 |
 | Partner Therapeutics Partner Therapeutics is committed to improving the lives of patients with cancer and other serious illnesses. WE'RE ALL IN FOR FIGHT AGAINST CANCER Partner Therapeutics is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients. We are united in our passion for improving the treatment of cancer and our desire to make a meaningful contribution to outcomes. THE PATIENT IS NUMBER ONE We believe that being a cancer company begins and ends with the patient. We strive to support patient needs throughout their treatment journey to help … Type: | 0 | 0 | 0 | 194 |
 | Deciphera Pharmaceuticals As a member of ONO Group As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com. | 0 | 0 | 0 | 412 |
 | Lockwood Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical and market access communications. Our clients count on us to challenge their assumptions, and help them creatively navigate around obstacles. From strategy through execution, we focus on accuracy, transparency, and scientific value to create programs that are evidence-based, clinically relevant, and contribute to the development of our clients’ brands. Over a third of our staff hold advanced scientific or medical degrees, and most work from where they live. Because our flexible structure provides better work-life balance, … Type: | 3 | 0 | 2 | 398 |
 | Diversity Alliance for Science The LIFE SCIENCE / HEALTHCARE Organization to get involved in! Since 2008, Diversity Alliance for Science has been the pre-eminent networking organization for life science companies and diverse-certified suppliers to connect, collaborate and drive the value of diversity. Our networking events are about genuine connections and finding the best way to spark innovation through building business relationships on our diverse perspectives. Our suppliers and corporations build their bottom lines by keeping our shared goals in mind: all the work they produce contributes to making medicines, devices, and ideas that save lives. The best way to get to know our organization … Type: | 20 | 0 | 16 | 12 |
 | mAbxience From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South … Type: | 6 | 2 | 3 | 984 |
 | TFS HealthScience Empowering Partners. Enriching Lives. TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With over 800 professionals operating across 40 countries, TFS delivers tailored clinical research services in specialized therapeutic areas, including dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO. For more information, visit www.tfscro.com. CRO, clinical trials, Scientific and Medical consulting, Contract Placement Solutions (staffing), Regulatory Consulting, Clinical Study Operations, … Type: | 4 | 1 | 1 | 791 |
 | Taconic Biosciences Leading the Industry in Animal Model Solutions. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world. Life Science … | 5 | 0 | 3 | 524 |
 | UroGen Pharma UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from … Type: | 1 | 0 | 1 | 238 |
 | European Cancer Patient Coalition The unified voice of cancer patients across Europe. Established in 2003, the European Cancer Patient Coalition is the voice of the European cancer patient community, uniquely representing the interests of all cancer patient groups from the major to the rarer cancers. It has been established to represent the views of cancer patients in the European healthcare debate and to provide a forum for European cancer patients to exchange information and share best practice experiences. ECPC works for a Europe of equality, where all European cancer patients have timely and affordable access to the best treatment and care available, throughout their … Type: | 13 | 3 | 10 | 7 |
 | Genovis We help Scientist build knowledge about their Biopharmaceuticals with our SmartEnzymesTM! Genovis offers a unique range of rapid and easy to use enzymatic tools primarily for the biopharmaceutical industry. Available worldwide, these SmartEnzymesTM are supplied in innovative formats for the development, production and quality control of biological drugs such as monoclonal antibodies, ADCs, biosimilars and bispecifics. The Genovis SmartEnzymes are widely used for the digestion, de-glycosylation and conjugation of the target molecule and are an ideal companion to popular analytical techniques like LC-MS. Within the portfolio there are enzymes specific for: IgG digestion - FabRICATORTM, FabALACTICATM, GingisKHANTM, FabULOUSTM & FabRICATOR … Type: | 1 | 0 | 0 | 42 |
 | Critical Path Institute (C-Path) Advancing Drug Development. Improving Lives. Together. Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona … Type: | 10 | 0 | 8 | 187 |
 | Medicines for Malaria Venture Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria Type: | 13 | 4 | 9 | 161 |
 | Symphogen Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers. oncology, immune-evasive, and AXL Type: | 0 | 0 | 0 | 189 |
 | Global Institute for Disease Elimination (GLIDE) We are a global health institute focused on accelerating the elimination of preventable infectious diseases. The Global Institute for Disease Elimination aims to be an innovative leader accelerating progress towards disease elimination to alleviate suffering and improve human lives. With an inter-disciplinary approach, the institute both advances the global understanding of elimination science and supports countries to translate knowledge into action in order to eliminate infectious diseases globally. neglected tropical diseases, malaria, polio, global health, capacity building, disease elimination, development, and NTDs Type: | 9 | 0 | 9 | 15 |
 | Max Delbrück Center Discovery for tomorrow's medicine The Max Delbrück Center for Molecular Medicine (MDC) conducts basic biomedical research with the aim of transferring research findings as soon as possible into clinical applications. Here the focus is on the diagnosis and treatment of diseases as well as on prevention. Research at the MDC is divided into four main areas: cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology. The MDC cooperates closely with the Charité - Universitätsmedizin Berlin and with the Berlin universities. Together with the Charité, the MDC has founded the Berlin Institute of Health (BIH). Imprint/Impressum: https://www.mdc-berlin.de/imprint … Type: | 17 | 3 | 12 | 842 |
 | Canadian Partnership Against Cancer A pan-Canadian partnership for better cancer outcomes. The Canadian Partnership Against Cancer is an independent organization funded by the federal government to accelerate action on cancer control for all Canadians. Our model is unique to addressing cancer, cooperating and collaborating across jurisdictions and organizations. Our efforts are collectively focused on the long-term objectives of reducing the incidence of cancer, reducing the likelihood of dying from cancer and improving the quality of life of those affected by cancer. Visit www.partnershipagainstcancer.ca to find out more. Type: | 2 | 0 | 1 | 186 |
 | Phathom Pharmaceuticals Going beyond to advance treatments for patients with acid-related disorders Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for … Type: | 1 | 0 | 1 | 396 |
 | PsychoGenics Discover Your Next Breakthrough PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into … Type: | 0 | 0 | 0 | 146 |
 | SOLTI #cancerresearch [Automatic translation follows] Innovative Breast Cancer Research SOLTI is a leading group in clinical cancer research in Spain. With a consolidated track record of more than 25 years, its main activity is focused on the design and execution of translational clinical studies within the academic field. Its interest has focused on breast cancer, but it opens its scope to other tumors. SOLTI has accumulated experience of 80 clinical trials and more than 30 in progress and is made up of 480 researchers in a network of 100 centers between Spain, Portugal and Ireland, coordinated by a central office in which … Type: | 10 | 0 | 10 | 115 |
 |  Cerba Research Transforming Research, Advancing Health Together At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation … Type: | 5 | 2 | 2 | 643 |
 | BioCryst Pharmaceuticals, Inc. We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HAE) and other rare diseases. BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices … Type: | 3 | 0 | 0 | 591 |
 | Centessa Pharmaceuticals A new kind of pharmaceutical company delivering asset centricity at scale. Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We are led by a management team with extensive R&D experience, providing direct guidance to our program teams to rapidly advance our candidates from research through all stages of development. We are headquartered in Boston, Massachusetts. | 2 | 1 | 1 | 83 |
 | Technopath Clinical Diagnostics LGC Clinical Diagnostics | Science for a Safer World Technopath Clinical Diagnostics is a global leader in the development, manufacturing and delivery of high quality independent quality controls and QC data management software for the In-Vitro Diagnostics industry. Our customers include hospitals, clinical laboratories, research facilities, CROs and blood banks in over 120 countries globally. Our partners equally are the leading innovators of clinical diagnostics instruments and systems and we collaborate with the most experienced academic institutions and reference laboratories in our research and development activities. In February 2021, Technopath joined LGC Clinical Diagnostics, a leading in vitro diagnostic (IVD) … Type: | 0 | 0 | 0 | 69 |
 | CMIC Group More than 80% of new drug development in Japan is supported by CMIC'S efforts. 実は、日本の新薬誕生の約8割に、私たちシミックの力が活かされています。 Voted Best Contract Research Organization (CRO) 2024 by Citeline CMIC Group was the first company to provide CRO (contract research organization) services in Japan. Relevant laws and rules had not been established when the group was first established. The CRO Study Group (which later became the Japan CRO Association) was formed by Mr. Kazuo Nakamura, the current CEO of CMIC Group, and others to conduct promotion and public relations activities and to negotiate with the authorities for the establishment of CROs in Japan. CMIC Group … Type: | 1 | 0 | 0 | 381 |
 | LETI Pharma Committed to the patient's health and wellbeing since 1919 LETI Pharma, the Experimental Laboratory for Immunogenic Therapeutics, is an independent, family-owned, biopharmaceutical company. Since its creation, in 1919, LETI Pharma has been working in immunotherapy based on the use of allergens, applying principals of personalized medicine, and a patient approach keeping with the “One Health” philosophy. LETIPharma integrates two lines of business, and several areas of work: HUMAN HEALTH - Immunology and Allergy, centered on the production of allergen extracts for allergy diagnosis and treatment. - Dermatology and skin care, which centers its activity on the development of dermo-pharmaceutical products … Type: | 0 | 0 | 0 | 572 |
 | Laboratorios Rubió More than 55 years working to ensure people have access to their medications, regardless of prevalence. For over 50 years, we have worked to ensure that everyone has access to our medications, regardless of their prevalence, thus improving their quality of life. #WeAreRubió Laboratorios Rubió was founded in 1968 with the goal of marketing medications that, at the time, were not available in our country because they were treatments for low-prevalence diseases. As pioneers in the first drug in Spain for the treatment of ADHD, today we have more than a dozen medications on the market, many of which are … Type: | 0 | 0 | 0 | 172 |
 | Phost'in Therapeutics Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology Type: | 11 | 6 | 7 | 14 |
 | ATP Nutrition Ltd. Restoring the Balance At ATP, we believe a proactive, science-based approach to restore the balance between plant and soil health is the single most effective way to deliver the genetic potential of the crop. We challenge the status quo by utilizing agtech to monitor and drive productivity. ATP is a leading supplier of essential plant nutrients helping growers across North America realize the genetic potential of their crop. Founded in 2010, the company simplified the complicated area of plant nutrition by developing the System of Chemtrition, an agronomically sound management plan built upon the R3 Agronomic Platform. In 2018, ATP … Type: | 0 | 0 | 0 | 30 |
 | Salvia BioElectronics Giving people with migraine a better life | Medical device company pioneering migraine therapy | Located in NL & AUS Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empower people with migraine to reclaim their lives. Our personalized migraine therapy is tailored to the needs of individual patients. And our ambition doesn’t stop there. With our unique bioelectronic technology, we are also exploring applications for other neurological disorders. Our unwavering commitment is driven by a deep desire to restore hope, health and … Type: | 2 | 0 | 2 | 51 |
 | Newbury Pharmaceuticals AB Your local champion and alternative partner Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rapidly growing and offer a product portfolio of specialty pharma medicines with focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, products based on peptide technology as well as biosimilars in a variety of therapeutic categories. The portfolio consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology representing more than 70 percent. The company was listed on Nasdaq First North, February 2022. Type: | 0 | 0 | 0 | 11 |
 | Faron A CLEVER Approach to Fight Cancer. Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. Its lead program is bexmarilimab, its investigative precision immunotherapy in Phase I/II development as a novel macrophage checkpoint immunotherapy for patients with hematological malignancies. Bexmarilimab is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Faron is based in Turku, Finland and Boston, Massachusetts. Faron is listed on AIM under the ticker ‘FARN’ and Nasdaq First North Growth Market ("Nasdaq First North") under ticker FARON. Drug discovery, Drug development, Pharmaceuticals, Novel treatments … Type: | 0 | 0 | 0 | 44 |
 | CombiGene CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace Nasdaq First North and the … Type: | 0 | 0 | 0 | 14 |
 | Patriapharma Complex APIs made in Hungary. Patriapharma is the international commercial partner of CF Pharma, Hungary, and draws on the pharmaceutical API development and manufacturing capabilities and extensive experience of its partner, whose R&D team maintains a highly specialized development pipeline. Pharmaceuticals and API-development | 0 | 0 | 0 | 24 |
 | IMIDomics Inc. Discovering and developing the next generation of medicines for immune-mediated inflammatory diseases (IMIDs) IMIDomics is a biotechnology company focused on Patient-Centric drug discovery for immune-mediated inflammatory diseases (IMIDs). Our goal is to discover new and impactful IMID drugs by focusing on carefully selected patients, and stratifying populations to identify those most likely to respond. IMIDomics is powered by a unique Clinical Discovery EngineTM, which integrates and analyzes proprietary clinical, epidemiological and patient-derived biomolecular datasets, generated in partnership with the Vall d’Hebron Institute of Research, to establish a deeper understanding of IMID diseases. By doing so, IMIDomics has identified previously unrecognized … Type: | 2 | 0 | 2 | 23 |
 | GlyProVac Exploring novel bacterial glycopeptide antigens to address unmet needs in vaccine development GlyProVac has via its proprietary platform technology, BEMAP, discovered that 1) O-linked protein glycosylation is a surprisingly abundant post translational modification in bacterial, 2) glycoproteins are linked to increased immunogenicity. GlyProVac aim to be the first to explore and exploit this novel class of antigens as candidates for vaccine development. The GlyProVac lead YghJ/SslE/AcfD is a conserved protein with a known biological function and has vaccine potential not only in ETEC but also in UPEC. Using BEMAP, GlyProVac has identified 59 glycosylated residues in YghJ. We are in … Type: | 0 | 0 | 0 | 11 |
 | HAWK Biosystems Unveiling protein function in patient samples to discovery breakthrough biomarkers. HAWK Biosystems (formerly FASTBASE Solutions) are a biosystems company founded in Bizkaia by Spanish and British scientists from the Francis Crick Institute in London. We have developed a technology that allows for the discovery and quantification of novel biomarkers within any disease state. Specifically, we can determine with high precision which patients will respond to immune-therapy and can stratify patients for treatment using our assay, QF-Pro®. We offer the QF-Pro® service which can be used to discover and quantify biomarkers in FFPE tissue and cell samples and we also offer … Type: | 4 | 0 | 0 | 22 |
 | SökerData AI-enabled platform providing access to correlated genomic and clinical datasets from under-represented groups AI-powered platform that accelerates access to correlated genomic and clinical datasets from under-represented groups (women and Black and ethnic minorities) in breast cancer and cardiovascular diseases. Type: | 2 | 0 | 2 | 4 |
 | KLISBio Silk innovation for life sciences KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for the creation of various solutions for endogenous tissue repair and regeneration. Silk is one of the most renowned and ancient materials used in medicine. In its raw state, silk consists of two main proteins, sericin and fibroin, with a glue-like layer of sericin coating two singular filaments of fibroin. Silk fibroin is fully biocompatible and promotes cell proliferation by also stimulating in-vivo tissue regeneration. Depending on the technology used, it provides a … Type: | 0 | 0 | 0 | 15 |
 | EnteroBiotix Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome. Type: | 1 | 0 | 1 | 53 |
 | Aerospec Holistic air pollution analysis to save lives by empowering individuals and governments to create a cleaner globe AeroSpec’s technology measures the chemical composition of air pollution - providing detailed analysis on its source, its makeup, and potential health effects. We provide comprehensive and actionable data that empowers research labs and environmental agencies to improve air quality and global health. High levels of particulate matter (PM) is associated with 7 million premature deaths worldwide and additional health effects. 84% of the global population is currently exposed to levels higher than recommended limits. Controlling air pollution requires informative monitoring, but understanding the … Type: | 3 | 1 | 2 | 6 |
 | Aelius Biotech Your gastrointestinal research partner. Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract. | 0 | 0 | 0 | 13 |
 | Concr Solving data to enable precision therapy for all Concr is a techbio company providing predictive modelling solutions to enhance confidence and foresight about therapeutic efficacy of existing and emerging cancer drugs. By accurately predicting response for individual patients and cohorts, we enable more efficacious and informative trials, thereby improving probability of success of novel cancer therapeutics. Our Farr-Sight® platform, built on decades of astrophysics research, models diverse data interactions to simulate human disease biology, enabling accurate predictions with minimal data. This is especially valuable in early-stage trials and rare cancers. Validated through collaborations with Roche, Step Pharma, The Institute of … Type: | 4 | 2 | 3 | 15 |
 | Ceroflo Advancing the Treatment of Intracranial Atherosclerotic Disease (ICAD) A new evolution in the treatment of Intracranial Atherosclerotic Disease (ICAD). | 0 | 0 | 0 | 11 |
 | Sable Bio Empowering Discovery: Precision Insights for Safer Drug Targets. Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies. Type: | 0 | 0 | 0 | 9 |
 | Autolus Therapeutics Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases. Type: | 0 | 0 | 0 | 643 |
 | PulmoBioMed Ltd. Your Breath, Your Health PulmoBioMed commercialises state-of-the-art exhaled breath condensate & aerosol sampling technology as part of a platform for disease and environmental diagnostics. Our lead product, PBM-HALE is a passive fluid aerosol sampler engineered to segregate exhaled and environmental particles by size. Our technology solves key pains in avoiding sample contamination, preventing sample loss and generating highly reproducible data with digital molecular precision. The first of a series of products, PBM-HALE has demonstrated utility in biological agent capture, genomic/microbiomic analytics, and metabolomic profiling, through a one-stop solution. Our vision is to develop the first hand-held biomolecular analyser for medical, … Type: | 1 | 1 | 0 | 8 |
 | Desentum Oy Imagine a world without allergies Desentum is a clinical-stage, research-oriented biopharmaceutical company specialized in developing novel types of allergy immunotherapy products (aka allergy vaccines) that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries that allow for improved design of vaccines against common types of allergies. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies … Type: | 0 | 0 | 0 | 9 |
 | Oxford Cannabinoid Technologies Holdings Plc A biotech company harnessing the therapeutic power of cannabinoids. Oxford Cannabinoid Holdings Plc is the holding company of Oxford Cannabinoid Technologies Ltd, a UK-based biotech company. We want to have a positive impact on the lives of people living with debilitating diseases and conditions and to change the narrative about cannabis for good. OCT has a range of compounds in drug development, including proprietary cannabinoid derivatives, phytocannabinoids and completely new chemical entities (NCEs) that target the endocannabinoid system. This maximises the therapeutic potential of cannabinoids. With experience across pharmaceutical operations, R&D, intellectual property, law and finance, OCT’s team is committed … Type: | 6 | 0 | 1 | 10 |
 | PepGen Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics Type: | 1 | 1 | 0 | 85 |
 | Orbis Medicines We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Type: | 1 | 0 | 1 | 20 |
 | AMPLY Discovery Novel Biologics. Designed by Evolution. Discovered by AI. Novel Biologics. Designed by Evolution. Discovered by AI. AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases. Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast. Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, and Bioinformatics Type: | 2 | 0 | 2 | 7 |
 | Curve Therapeutics Revolutionary intracellular screening platform enables a new generation of first-in-class drugs. Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged. Our Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes. We are deploying our innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets. Type: | 2 | 0 | 2 | 32 |
 | Protonify Corporation Highest purity, lowest cost THCA isolate & Delta-9 THC extract at industrial scale. 100% total cannabinoid inputs. Highest purity, lowest-cost THCA Isolate & pure Delta-9 THC extract at industrial scale. 100% total cannabinoid inputs used by formulators to create differentiated product SKUs in recreational, medical and bio-pharma markets. Recreational use cases include Diamond-infused pre-rolls, Liquid Diamond vapes, edibles, beverages. THC Formulation, THC Packaging, Medical Cannabis, Isolation and Extraction, Licensing, Intellectual Property, Global Sales and Marketing, THC Isolation, THCa API, THC API, THCa Isolation, Crystalization, and High Purity Intermediaries Type: | 0 | 0 | 0 | 10 |
 | Karyosoft Inc. In-House No-Code Genomics Platform helping Geneticists for Enhanced Research Efficiency and Accelerated Innovations We offer time and cost saving in-house, secure no-code genomics data management, analytics and visualization platform for molecular geneticists, bioinformaticians for enhanced research efficiency and accelerated innovations in agrigenomics and life sciences organizations. We offer no-code genomics software solutions for common challenges routinely that geneticists and bioinformaticians face in their NGS workflow specifically in secondary and tertiary analyses. Our platforms have been proven to create values for the life scientists and their organizations by saving time and cost, accelerating time to market and by providing higher data … Type: | 1 | 0 | 1 | 4 |
 | Lantern Pharma Inc. (Nasdaq: LTRN) Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR … Type: | 1 | 0 | 1 | 28 |
 | MedUniverse Bridging the information gap between pharma and healthcare professionals using the power of interactive patient cases. MedUniverse helps the Life Sciences Industry to drive increased HCP engagement and results through the power of interactive patient case studies. The company has more than 15 global pharmaceutical companies as customers, within more than 20 therapeutic areas in 40+ markets worldwide. The vision is to become the industry standard platform for engagement and dialogue between HCPs and life sciences companies, ultimately improving patient outcomes. Pharmaceutical marketing, medical education, MedEd, Sales Forces Effectiveness, Multi channel marketing, digital, patient case, HCP Engagement, Healthcare professional engagement, … Type: | 4 | 1 | 5 | 17 |
 | Sequence Bio Discovering the true signals of disease to power life-changing medicines. 90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that with better, faster drug target discovery powered by the Newfoundland founder effect. Biotechnology and Drug Discovery Type: | 4 | 0 | 3 | 17 |
 | Coloursmith Labs Inc. Advancing Vision Care with Next-Generation Light-Filtering Technology Coloursmith is pioneering the future of vision care with advanced light-filtering technology that elevates contact lenses to new levels of functionality and performance. Our patented platform enables the development of lenses that not only enhance visual comfort but also support eye health and lifestyle needs, meeting the growing demand for specialized vision solutions. Rooted in cutting-edge R&D and driven by a commitment to excellence, Coloursmith partners with leading industry players to bring innovative lens solutions to market. We focus on creating value through technology that empowers vision care companies to differentiate their products … Type: | 0 | 0 | 0 | 10 |
 | BiOWiSH Technologies Power your biology. Produce more with BiOWiSH® As much as 99% of bacteria in the natural world can’t be seen with the human eye and are unknown. Uncovering the secrets of microbes & biodiversity should be the scientific quest for our era. BiOWiSH® provides industry-leading biotechnology solutions for the agriculture and environmental management industries. Our product range is proven to deliver consistent performance globally for agricultural applications, aquaculture production, and the water treatment industry. Led by former P&G scientists and senior executives based in Cincinnati, Ohio, the company has formed partnerships with leading research institutions around the world, to explore … Type: | 0 | 0 | 0 | 55 |
 | Dalan Animal Health, Inc. We bring the world transformative animal health solutions supporting a more sustainable future. Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet. Type: | 1 | 0 | 1 | 25 |
 | Nicoya Our mission is to improve human life by helping scientists succeed. Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at the forefront of nanotechnology and biotechnology sectors. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. Alto, the world’s first digital high-throughput benchtop SPR instrument, … Type: | 3 | 0 | 3 | 103 |
 | Pear Bio Patient-centered cancer precision medicine Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and drug discovery. Our ultimate goal is to optimally allocate approved treatments to cancer patients who will benefit from them, while creating novel therapies that are purpose-designed for patients who don't respond to available treatments. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples with matched blood into 3D immune-microtumors to test potential treatment options and combinations ex vivo. … Type: | 3 | 1 | 0 | 36 |
 | BioCorteX We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work Type: | 1 | 1 | 0 | 15 |
 | MEDIBIOFARMA SL To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies Type: | 0 | 0 | 0 | 8 |
 | Modus Therapeutics Holding AB We develop sevuparin to help patients with severe conditions and high unmet medical need. Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition. Sepsis, Systemic inflammation, Heparinoids, Pharmaceutical development, and Pharmaceutical research Type: | 0 | 0 | 0 | 4 |
 | HOOKIPA Pharma Inc. Supercharging Immunotherapy At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV … Type: | 4 | 1 | 3 | 124 |
 | heydayskincare Type: | 1 | 1 | 0 | 149 |
 | InnaVirVax InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies. InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the … Type: | 0 | 0 | 0 | 0 |
 | DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … Type: | 8 | 4 | 1 | 26 |
 | Unibiome (Peer To Peer Probiotics) Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification Type: | 0 | 0 | 0 | 1 |
 | CITRAGE, Stratégies nutritionnelles innovantes dédiées à la santé des séniors [Automatic translation follows] CITRAGE is a research and development company in the field of health nutrition. It develops in partnership with the University of Paris Descartes food supplements and oral nutritional supplements intended for people over 50 years old. The two main products are made up of 100% L-Citrulline, a non-protein amino acid, having a direct action on muscle protein synthesis, thus optimizing the use of other amino acids and allowing better maintenance of muscles. - MyoCIT is a food supplement to preserve muscle capital during aging, it is intended for young seniors in prevention of age-related muscle wasting (causing … Type: | 0 | 0 | 0 | 7 |
 | Theranexus Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous. Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease. Type: | 12 | 7 | 5 | 14 |
 | Cyrebro Neurosignals [Automatic translation follows] myBrain Tech becomes CYREBRO NEUROSIGNALS myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics and to extract informative insight to better understand the impact of their product or service on their users' brains. Our team of neuroscientists and data scientists develops algorithms and automated dashboards to analyze and interpret human EEG and behavioral data in real life context, and create strategic AI Model. myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics and to extract informative insight to better understand the impact of their product or services on their users' brains. … Type: | 30 | 15 | 17 | 13 |
 | InVenis Biotherapies Platelet-derived Regenerative Therapy for CNS Disorders InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis. Type: | 7 | 5 | 1 | 2 |
 | MED'INN'Pharma A clinic-ready biotech developing human cell-derived secretome drugs to cure inflammation-related pathologies Med’Inn’Pharma (MIP) is a clinic-ready Biotech company that was founded in 2017 as a spin-off from the French blood bank establishment (EFS) and of the French National Institute of Health (INSERM). MIP is a pioneer in developing a new class disease modifying therapies dedicated to resolve pathologic inflammation in a wide range of degenerative diseases and conditions. Our founders are world leaders in immunology and inflammation-resolution, and have developed a patent protected process to harness bioactive molecules from physiologically conditioned human cells into a stable biologic drug product. … Type: | 4 | 3 | 1 | 5 |
 | Cellaven Cell culture automation, simple and affordable, for R&D laboratories Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only). biotechnology, automated cell culture, and 3D cell culture Type: | 8 | 8 | 0 | 4 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … Tags: FrenchTech120 FrenchTech2030 Type: | 49 | 24 | 31 | 166 |
 | YSOPIA Bioscience Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota Type: | 4 | 2 | 3 | 4 |
 | GATACA SYSTEMS Gataca Systems builds and integrates modular systems to perform the most demanding imaging and photo-manipulation techniques. Thus, we can integrate all the following techniques on new and existing microscope : Ring TIRF, FRAP, Photo-activation, Photo-ablation, Micropatterning, Single Molecule Super-Resolution, Live Confocal Super-Resolution, SPIM, Multichannel Detection (up to 4 channels), triple output high-power laser launches. All combinations can be done in a simultaneous manner. For more info : info@gataca-systems.fr www.gataca-systems.com spinning disk, TIRF microscopy, super resolution microscopy, FRAP microscopy, metamorph software, and Scientific cameras Type: | 0 | 0 | 0 | 6 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 2 | 1 | 1 | 13 |
SMB